Quipt Home Medical Crecimiento futuro

Future controles de criterios 4/6

Quipt Home Medical se prevé un crecimiento anual de los beneficios y los ingresos de 62% y 20.8%, respectivamente, mientras que el BPA aumentará de grow a 59.2%.

Información clave

54.8%

Tasa de crecimiento de los beneficios

52.0%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Healthcare	15.7%
Tasa de crecimiento de los ingresos	16.2%
Rentabilidad financiera futura	n/a
Cobertura de analistas	Good
Última actualización	03 Apr 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Previsiones de crecimiento de beneficios e ingresos

NasdaqCM:QIPT - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
9/30/2026	351	18	N/A	N/A	2
9/30/2025	290	7	N/A	N/A	6
9/30/2024	267	0	45	52	8
12/31/2023	236	-4	40	47	N/A
9/30/2023	212	-3	34	41	N/A
6/30/2023	189	0	26	34	N/A
3/31/2023	164	2	19	29	N/A
12/31/2022	139	7	17	26	N/A
9/30/2022	128	5	17	26	N/A
6/30/2022	118	2	17	26	N/A
3/31/2022	109	8	15	23	N/A
12/31/2021	99	-10	14	20	N/A
9/30/2021	94	-6	13	18	N/A
6/30/2021	87	-5	13	16	N/A
3/31/2021	81	-14	14	15	N/A
12/31/2020	79	1	13	14	N/A
9/30/2020	73	-4	14	14	N/A
6/30/2020	67	0	19	19	N/A
3/31/2020	62	-6	10	10	N/A
12/31/2019	63	-11	10	10	N/A
9/30/2019	61	-7	8	8	N/A
6/30/2019	57	-27	10	2	N/A
3/31/2019	56	-18	14	11	N/A
12/31/2018	53	-20	10	10	N/A
9/30/2018	55	-7	10	11	N/A
6/30/2018	59	-6	-5	-4	N/A
3/31/2018	59	-7	-6	-3	N/A
12/31/2017	61	-4	-8	-6	N/A
9/30/2017	61	-22	N/A	-5	N/A
6/30/2017	36	-16	N/A	1	N/A
3/31/2017	45	-19	N/A	-8	N/A
12/31/2016	56	-29	N/A	-7	N/A
9/30/2016	73	-28	N/A	-12	N/A
6/30/2016	105	-18	N/A	-9	N/A
3/31/2016	94	-25	N/A	-10	N/A
12/31/2015	73	-16	N/A	-6	N/A
9/30/2015	54	-18	N/A	-2	N/A
6/30/2015	42	-21	N/A	-4	N/A
3/31/2015	30	-7	N/A	3	N/A
12/31/2014	25	-4	N/A	0	N/A
9/30/2014	19	-1	N/A	-1	N/A
6/30/2014	12	0	N/A	0	N/A
3/31/2014	7	-1	N/A	-1	N/A
12/31/2013	5	-2	N/A	-1	N/A
9/30/2013	4	-2	N/A	-1	N/A
6/30/2013	4	0	N/A	0	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: QIPT se prevé que sea rentable en los próximos 3 años, lo que se considera un crecimiento más rápido que la tasa de ahorro (2.2%).

Beneficios vs. Mercado: QIPT se prevé que sea rentable en los próximos 3 años, lo que se considera un crecimiento del mercado superior a la media.

Beneficios de alto crecimiento: QIPT se espera que sea rentable en los próximos 3 años.

Ingresos vs. Mercado: QIPTSe prevé que los ingresos de la empresa (20.8% al año) crezcan más deprisa que los del mercado US (8.1% al año).

Ingresos de alto crecimiento: QIPTSe prevé que los ingresos de la empresa (19% al año) crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Datos insuficientes para determinar si la Rentabilidad de los fondos propios de QIPT se prevé elevada dentro de 3 años.

Descubre empresas en crecimiento

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Quipt Home Medical Crecimiento futuro

Future controles de criterios 4/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Price target decreased by 14% to US$9.50

Price target increased to US$11.22

Quipt Home Medical Corp. Reiterates Outlook for 2022

Price target decreased to US$10.22

Quipt Home Medical Corp. Reiterates Revenue Guidance for the First Quarter of Fiscal Year 2023

Price target decreased to US$10.48

Recent updates

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Quipt Home Medical Corp., Annual General Meeting, Mar 27, 2024

Quipt Home Medical Corp. to Report Q1, 2024 Results on Feb 14, 2024

Price target decreased by 14% to US$9.50

Full year 2023 earnings: EPS and revenues miss analyst expectations

Quipt Home Medical Corp. to Report Q4, 2023 Results on Dec 18, 2023

Now 21% undervalued after recent price drop

Third quarter 2023 earnings: EPS misses analyst expectations

Now 20% undervalued after recent price drop

Quipt Home Medical Corp.(TSXV:QIPT) dropped from S&P/TSX Venture Composite Index

Now 20% undervalued after recent price drop

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Investor sentiment deteriorates as stock falls 15%

First quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Quipt Home Medical Corp., Annual General Meeting, Mar 24, 2023

Investor sentiment improved over the past week

Price target increased to US$11.22

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Quipt Home Medical receives commitment letter for $80M of credit facilities

Quipt Business Progresses, Stock Price Should Soon Follow

Quipt Home Medical Corp. (TSXV : QIPT) acquired Hometown Medical, LLC.

Quipt acquires Hometown Medical, scoops fourth firm in four months

Quipt: At A Turning Point, Seeking 40% Return Objective

Quipt Home Medical Corp. Reiterates Outlook for 2022

Quipt Home Medical Corp. (TSXV:QIPT) acquired Norcal Respiratory, Inc. for $3.1 million.

Second quarter 2022 earnings: EPS exceeds analyst expectations

Price target decreased to US$10.22

Quipt Home Medical Corp. Reiterates Revenue Guidance for the First Quarter of Fiscal Year 2023

Price target decreased to US$10.48

Quipt Home Medical Corp., Annual General Meeting, Jun 02, 2022

Quipt Convertible Debenture Hedging Provides An Incredible Opportunity

Quipt Home Medical Corp. Provides Earnings Guidance for the First Quarter of Fiscal Year 2023

Quipt Home Medical Corp. Appoints Brian J. Wessel as an Independent Director and Chair of the Audit Committee

Forecast breakeven date pushed back to 2023

Full year 2021 earnings: EPS misses analyst expectations

Quipt Home Medical Corp Receives Letter from Nasdaq Notifying Nom-Compliance

Quipt Home Medical Corp. Reiterates Earnings Guidance for the Fiscal Year 2022

Quipt Home Medical Corp. (TSXV:QIPT) completed the acquisition of At Home Health Equipment, Inc. for approximately $13.1 million.

Quipt Home Medical Corp. Provides Earnings Guidance for the Fiscal Year 2022

Quipt's Recent Announcements Signal Good Times Ahead

Price target increased to US$12.17

Quipt Home Medical: Acquisitions And Earnings Breathe Life Back Into Shares

Third quarter 2021 earnings released: EPS US$0.20 (vs US$0.12 loss in 3Q 2020)

Quipt Home Medical Corp. (TSXV:QIPT) acquired Medical West Healthcare Center, LLC for $2.4 million.

Quipt: Warrant Overhang Creates Attractive Prices

Forecast breakeven moved forward to 2021

Protech Home Medical Corp., Annual General Meeting, Apr 19, 2021

Protech Home Medical Corp. (TSXV:PTQ) completed the acquisition of Mayhugh's Medical Equipment for $5.8 million.

Protech Home Medical Corp. to Report Q4, 2020 Results on Jan 29, 2021

Protech Home Medical Announces That Kevin A. Carter Has Joined the Board of Directors as an Independent Director

Protech Home Medical Corp. (TSXV:PTQ) completed the acquisition of Sleepwell, LLC for $14.4 million.

Protech Home Medical Corp. (TSXV:PTQ) completed the acquisition of Health Technology Resources, LLC.

Protech Home Medical Corp. has completed a Composite Units Offering in the amount of CAD 25.001 million.

Previsiones de crecimiento de beneficios e ingresos

Previsiones de crecimiento futuro de los analistas

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

Descubre empresas en crecimiento